Caelus investment among J&J's microbiome deals

The Janssen Human Microbiome Institute (JHMI) of Johnson & Johnson (NYSE:JNJ) announced three microbiome-related deals Thursday, including an equity investment in

Read the full 213 word article

How to gain access

Continue reading with a
two-week free trial.